Doseology Sciences Inc. (MOOD.CN)

CAD 0.4

(8.11%)

Revenue Summary of Doseology Sciences Inc.

  • Doseology Sciences Inc.'s latest annual revenue in 2023 was 98.52 Thousand CAD , up 128.65% from previous year.
  • Doseology Sciences Inc.'s latest quarterly revenue in 2023 Q4 was 5296.00 CAD , down -84.35% from previous quarter.
  • Doseology Sciences Inc. reported a annual revenue of 43.08 Thousand CAD in annual revenue 2022, up 168.49% from previous year.
  • Doseology Sciences Inc. reported a annual revenue of 16.04 Thousand CAD in annual revenue 2021, down 0.0% from previous year.
  • Doseology Sciences Inc. reported a quarterly revenue of 33.85 Thousand CAD for 2023 Q3, up 155.02% from previous quarter.
  • Doseology Sciences Inc. reported a quarterly revenue of 46.1 Thousand CAD for 2023 Q1, up 316.86% from previous quarter.

Annual Revenue Chart of Doseology Sciences Inc. (2023 - 2019)

Historical Annual Revenue of Doseology Sciences Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 98.52 Thousand CAD 128.65%
2022 43.08 Thousand CAD 168.49%
2021 16.04 Thousand CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%

Peer Revenue Comparison of Doseology Sciences Inc.

Name Revenue Revenue Difference
Algernon Pharmaceuticals Inc. - CAD -Infinity%
Asep Medical Holdings Inc 21.14 Thousand CAD -366.045%
BetterLife Pharma Inc. - CAD -Infinity%
BioVaxys Technology Corp. - CAD -Infinity%
ChitogenX Inc. - CAD -Infinity%
Rapid Dose Therapeutics Corp. 1.02 Million CAD 90.345%
Defence Therapeutics Inc. - CAD -Infinity%
Entheon Biomedical Corp. 250.32 Thousand CAD 60.642%
Gemina Laboratories Ltd. - CAD -Infinity%
Glow Lifetech Corp. 43.93 Thousand CAD -124.265%
Lexston Life Sciences Corp. - CAD -Infinity%
Pharmala Biotech Holdings Inc. 532 Thousand CAD 81.481%
MYND Life Sciences Inc. - CAD -Infinity%
Nova Mentis Life Science Corp. 28.34 Thousand CAD -247.569%
PharmaTher Holdings Ltd. - CAD -Infinity%
PreveCeutical Medical Inc. - CAD -Infinity%
Telescope Innovations Corp. 595.39 Thousand CAD 83.453%